Join to View Full Profile
705 Riley Hospital Dr# RocIndianapolis, IN 46202
Phone+1 317-944-2143
Fax+1 317-944-3107
Dr. Rhodes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Indiana University School of MedicineClass of 2014
Certifications & Licensure
IN State Medical License 2018 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Clinical Trials
- Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas Start of enrollment: 2025 Jun 15
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- PLK1 inhibition induces synthetic lethality in Fanconi anemia pathway-deficient acute myeloid leukemia.Aditya S Sheth, Ka-Kui Chan, Sheng Liu, Jun Wan, Steven P Angus
Cancer Research Communications. 2025-03-20 - 1 citationsSelumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.Andrea M Gross, Geraldine O'Sullivan Coyne, Eva Dombi, Cecilia Tibery, William G Herrick
Nature Medicine. 2025-01-01 - 2 citationsEfficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children's Oncology Group.Elliot Stieglitz, Alex G Lee, Steven P Angus, Christopher Davis, Donald A Barkauskas
Cancer Discovery. 2024-09-04
Journal Articles
- A Proteasome-Resistant Fragment of NIK Mediates Oncogenic NF-κB Signaling in SchwannomasGeorge Sandusky, Jeffrey R Gehlhausen, Charles W Yates, Steven D Rhodes, Grzegorz Nalepa, Eric Hawley, Jacquelyn D Lajiness, Benjamin Mark Wahle, Human Molecular Genetics
Grant Support
- T cells in neurofibroma pathogenesis and malignanttransformationINDIANA UNIVERSITY INDIANAPOLIS2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
